InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Sharp Phillip A, 董事. Director active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 7 reports have been logged. History available since 21 May 2021. The latest transaction was filed on 23 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sharp Phillip A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
11,250 股@ US$131.2131.2% 占其流量Common StockSEC:0001735276-25-000002:0
30,000 股@ US$59.2536.1% 占其流量Common StockSEC:0001735276-24-000022:0
6,027 股0Common StockSEC:0001209191-23-031842:0
30,000 股@ US$30.0919.6% 占其流量Common StockSEC:0001735276-22-000069:0
6,405 股0Common StockSEC:0001209191-22-031961:0
30,000 股@ US$11.337.0% 占其流量Common StockSEC:0001735276-22-000014:0
3,374 股0Common StockSEC:0001209191-21-035716:0
7 条申报中的 7 条
About Sharp Phillip A
Phillip A. Sharp is a Board Member at Vir Biotechnology, Inc. and ALNYLAM PHARMACEUTICALS, INC. He brings his expertise in the biopharmaceutical field, contributing to the strategy and governance of the companies. His experience is an asset for the development of these firms.
